Mylan Receives FDA Approval for Additional Strength of Generic Restoril(R)
Product shipment has begun
Temazepam Capsules are the generic version of Mallinckrodt’s Restoril(R), a sleep aid, which had total U.S. sales of approximately
Currently, Mylan has 118 ANDAs pending FDA approval representing
Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generics and specialty pharmaceutical companies in the world. The company maintains one of the industry’s broadest – and highest quality – product portfolios, supported by a robust product pipeline; owns a controlling interest in the world’s third largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. For more information, please visit www.mylan.com.
SOURCE Mylan Inc.